Trauma and Extremities Market (By Composition: Internal Fixation Devices [Rods and Pins, Plates and screws, Bone Grafts], Craniofacial Devices [Internal Craniofacial Devices, External Craniofacial Devices], Long Bone Stimulation, External Fixation Devices, Other Trauma Devices; By Type: Lower Extremities, Upper Extremities, Shoulder, Hip Fracture And Pelvic, Foot And Ankle) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Trauma and Extremities
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Trauma and Extremities Market By Composition
1.2.2.1. Global Trauma and Extremities Market Revenue and Growth Rate Comparison By Composition (2015-2026)
1.2.2.2. Global Trauma and Extremities Market Revenue Share By Composition in 2017
1.2.2.3. Internal Fixation Devices
1.2.2.3.1. Rods and Pins
1.2.2.3.2. Plates and screws
1.2.2.3.3. Bone Grafts
1.2.2.4. Craniofacial Devices
1.2.2.4.1. Internal Craniofacial Devices
1.2.2.4.2. External Craniofacial Devices
1.2.2.5. Long Bone Stimulation
1.2.2.6. External Fixation Devices
1.2.2.7. Other Trauma Devices
1.2.3. Trauma and Extremities Market By Type
1.2.3.1. Global Trauma and Extremities Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.3.2. Global Trauma and Extremities Market Revenue Share By Type in 2017
1.2.3.3. Lower Extremities
1.2.3.4. Upper Extremities
1.2.3.5. Shoulder
1.2.3.6. Hip Fracture And Pelvic
1.2.3.7. Foot And Ankle
1.2.4. Trauma and Extremities Market by Geography
1.2.4.1. Global Trauma and Extremities Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Trauma and Extremities Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Trauma and Extremities Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Trauma and Extremities Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Trauma and Extremities Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Trauma and Extremities Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Trauma and Extremities Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Trauma and Extremities Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Trauma and Extremities Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Trauma and Extremities Major Manufacturers in 2017

CHAPTER 4. TRAUMA AND EXTREMITIES MARKET BY COMPOSITION

4.1. Global Trauma and Extremities Revenue By Composition
4.2. Internal Fixation Devices
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Rods and Pins
4.2.4. Plates and screws
4.2.5. Bone Grafts
4.3. Craniofacial Devices
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Internal Craniofacial Devices
4.3.4. External Craniofacial Devices
4.4. Long Bone Stimulation
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. External Fixation Devices
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other Trauma Devices
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. TRAUMA AND EXTREMITIES MARKET BY TYPE

5.1. Global Trauma and Extremities Revenue By Type
5.2. Lower Extremities
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Upper Extremities
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Shoulder
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Hip Fracture And Pelvic
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Foot And Ankle
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA TRAUMA AND EXTREMITIES MARKET BY COUNTRY

6.1. North America Trauma and Extremities Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Trauma and Extremities Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Trauma and Extremities Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE TRAUMA AND EXTREMITIES MARKET BY COUNTRY

7.1. Europe Trauma and Extremities Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Trauma and Extremities Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC TRAUMA AND EXTREMITIES MARKET BY COUNTRY

8.1. Asia-Pacific Trauma and Extremities Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Trauma and Extremities Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA TRAUMA AND EXTREMITIES MARKET BY COUNTRY

9.1. Latin America Trauma and Extremities Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Trauma and Extremities Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST TRAUMA AND EXTREMITIES MARKET BY COUNTRY

10.1. Middle East Trauma and Extremities Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Trauma and Extremities Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA TRAUMA AND EXTREMITIES MARKET BY COUNTRY

11.1. Africa Trauma and Extremities Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Trauma and Extremities Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Composition, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Dow DePuy Synthes
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Wright Medical Group, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Koninklijke Philips N.V.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Boston Scientific Corporation
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Braun Melsungen AG
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Stryker Corporation
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Zimmer Biomet
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. GE Healthcare
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Zimmer Biomet Holdings, Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Johnson & Johnson Services, Inc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Becton Dickinson and Company
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Siemens
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Cardinal Health
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Abbott
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. Others
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope


Cart Summary